BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17408800)

  • 1. Strength-duration properties in diabetic polyneuropathy.
    Yerdelen D; Koç F; Uysal H; Sarica Y
    Diabetes Res Clin Pract; 2007 Oct; 78(1):56-9. PubMed ID: 17408800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hyperventilation on strength-duration properties in diabetic polyneuropathy.
    Yerdelen D; Uysal H; Koç F; Sarica Y
    Clin Neurophysiol; 2007 Jan; 118(1):105-10. PubMed ID: 17095293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strength-duration properties of sensory and motor axons in alcoholic polyneuropathy.
    Yerdelen D; Koc F; Uysal H
    Neurol Res; 2008 Sep; 30(7):746-50. PubMed ID: 18489821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sex and age on strength-duration properties.
    Yerdelen D; Uysal H; Koc F; Sarica Y
    Clin Neurophysiol; 2006 Sep; 117(9):2069-72. PubMed ID: 16875875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve excitability properties in early preclinical diabetic neuropathy.
    Erdoğan C; Yücel M; Değirmenci E; Öz O; Akgün H; Odabaşı Z
    Diabetes Res Clin Pract; 2011 Oct; 94(1):100-4. PubMed ID: 21741106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.
    Tamura N; Kuwabara S; Misawa S; Mori M; Nakata M; Hattori T
    Clin Neurophysiol; 2005 Oct; 116(10):2330-3. PubMed ID: 16122982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve excitability changes in critical illness polyneuropathy.
    Z'Graggen WJ; Lin CS; Howard RS; Beale RJ; Bostock H
    Brain; 2006 Sep; 129(Pt 9):2461-70. PubMed ID: 16901913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of hyperventilation on axonal excitability parameters in patients with diabetes mellitus and polyneuropathy.
    Akça G; Yerdelen D; Balcı MK; Uysal H
    Diabetes Res Clin Pract; 2016 Aug; 118():112-20. PubMed ID: 27368063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV; Lin CS; Kiernan MC
    Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Italian multicentre study on the prevalence of distal symmetric polyneuropathy: correlation between clinical variables and nerve conduction parameters. Italian Diabetic Neuropathy Committee.
    Comi G; Fedele D; Coscelli C; Cucinotta D; Feldman EL; Ghirlanda G; Negrin P; Santeusanio F; Maderna L
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():546-52. PubMed ID: 10689507
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.
    Kanai K; Kuwabara S; Misawa S; Tamura N; Ogawara K; Nakata M; Sawai S; Hattori T; Bostock H
    Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic polyneuropathy. Axonal or demyelinating?
    Valls-Canals J; Povedano M; Montero J; Pradas J
    Electromyogr Clin Neurophysiol; 2002; 42(1):3-6. PubMed ID: 11851006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.
    Sawai S; Kanai K; Nakata M; Hiraga A; Misawa S; Isose S; Hattori T; Kuwabara S
    Clin Neurophysiol; 2008 May; 119(5):1097-105. PubMed ID: 18342570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of hypothyroidism on strength-duration properties of peripheral nerve.
    Yerdelen D; Ertorer E; Koç F
    J Neurol Sci; 2010 Jul; 294(1-2):89-91. PubMed ID: 20452625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological patterns of diabetic polyneuropathy.
    Bagai K; Wilson JR; Khanna M; Song Y; Wang L; Fisher MA
    Electromyogr Clin Neurophysiol; 2008; 48(3-4):139-45. PubMed ID: 18551834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of botulinum toxin on strength-duration properties.
    Yerdelen D; Koc F; Sarica Y
    Int J Neurosci; 2007 Oct; 117(10):1457-64. PubMed ID: 17729156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
    Genç G; Bek S; Kasikci T; Ulas UH; Demirkaya S; Odabasi Z
    Mult Scler Int; 2012; 2012():390157. PubMed ID: 22645684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent postoperative complaints after whole sural nerve biopsies in diabetic and non-diabetic subjects.
    Dahlin LB; Eriksson KF; Sundkvist G
    Diabet Med; 1997 May; 14(5):353-6. PubMed ID: 9171249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sural/radial nerve amplitude ratio: reference values in healthy subjects.
    Overbeek BU; van Alfen N; Bor JA; Zwarts MJ
    Muscle Nerve; 2005 Nov; 32(5):613-8. PubMed ID: 16116641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of mexiletine on excitability properties of human median motor axons.
    Kuwabara S; Misawa S; Tamura N; Kanai K; Hiraga A; Ogawara K; Nakata M; Hattori T
    Clin Neurophysiol; 2005 Feb; 116(2):284-9. PubMed ID: 15661106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.